Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com

Imipridones Publications

imipridones

ONC201 and imipridones: Anti-cancer compounds with clinical efficacy

Neoplasia 2020 PMID: 33142238

Prabhu VV, Morrow S, Kawakibi AR, et al.

imipridones

Metabolic reprogramming by dual AKT/ERK inhibition through imipridones elicits unique vulnerabilities in glioblastoma

Clin Cancer Res. 2018 PMID: 30037819

Ishida CT, Zhang Y, Bianchetti E, et al.

imipridones

Defining structure activity relationships for GPCR engagement and anti-cancer efficacy of imipridone small molecules

ACR Annual Meeting 2019

Prabhu VV, Kawakibi AR, Madhukar NS, et al.

imipridones

Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality

Cancer Cell 2019 PMID: 31056398

Ishizawa J, Zarabi SF, Davis RE, et al.

imipridones

Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212

Cell Cycle. 2017 PMID: 28489985

Wagner J, Kline CL, Ralff MD, et al.